Identification: SYM08
Peripheral vs. Central: ECMO in PAH Patients
Elie Fadel, MD
OxyRVAD: Who is a Candidate?
Charles Hoopes, MD
ECMO in Pediatric Patients with PAH: What are the Particularities?
Pirooz Eghtesady, MD
ECMO in Non-PAH Pulmonary Hypertension: Clots and Scars
Walter Klepetko, MD
Preview Available
Identification: SYM09
Introduction and Recognition of Top Papers of the Year
Patricia Uber, PharmD
Highlights of Heart Transplantation and Mechanical Circulatory Support
Agnieszka Ciarka, MD
Senior Editor Perspective: Heart Transplantation and Mechanical Circulatory Support
Hermann Reichenspurner, MD, PhD
Highlights of Lung Transplantation and Pulmonary Hypertension
Hrishikesh Kulkarni, MD
Senior Editor Perspective: Lung Transplantation and Pulmonary Hypertension
Andrew Fisher, FRCP, PhD
Highlights of Pediatric Heart and Lung Transplantation
Erin Albers, MD
Senior Editor Perspective: Pediatric Heart and Lung Transplantation
Jennifer Conway, MD
Highlights of Infectious Diseases
Saima Aslam, MD, MS
Senior Editor Perspective: Infectious Diseases
Margaret Hannan, MD
Identification: SS01
Invasive Exercise Hemodynamic Evaluation in LVAD Patients
David Kaye, MD, PhD
Factors Influencing Exercise Performance in LVAD Patients
Stuart Russell, MD
Pulsatility and Exercise Performance in Continuous vs. Pulsatile Flow
Christopher Hayward, MD
Right Ventricular Function During Exercise in LVAD Patients
Finn Gustafsson, MD, PhD
Preview Available
Identification: SS02
Chronic Chagas Disease and Chagasic Cardiomyopathy
Anna Sa, MD
Arrhythmic Storm as the First and Last Manifestation of Chagas Disease
Fabiana Marcondes-Braga, MD, PhD
Heart Transplant in Chagasic Cardiomyopathy: How to Manage Immunosuppression
Fernando Bacal, MD, PhD
Reactivation of Chagas Post-Transplant: Diagnosis and Pharmaceutical Management
Lisa Peters, PharmD
Preview Available
Identification: SS03
Lifecycle Journey Case Presentation
Christina Doligalski, PharmD, BCPS
Influence of Surgical Techniques on Pump Thrombosis: How Physics Can Help Patient Management
Daniel Zimpfer, MD
Lifecycle Journey Case Update
Christina Doligalski, PharmD, BCPS
Prevention of Thrombosis in Mechanical Support: Where are we going?
Ed Horn, PharmD
Lifecycle Journey Case Update
Christina Doligalski, PharmD, BCPS
What Pathology Can Tell Us About Mechanisms of Thrombosis
Lisa Baumann Kreuziger, MD
Preview Available
Identification: SS04
The Crucial Importance of PROs for Transplant Evaluation from a Clinical, Research and Quality Assurance Perspective
Linda Ohler, MSN, FAAN
State of the Art Development of PRO Assessments for Patient Centered Outcomes Research (PCOR)
Sabina De Geest, RN, PhD
PROs in Pediatric Transplant Patients: Special Issues
Kathleen Grady, PhD, APN, FAAN
Preview Available
Identification: SS05
Bridge over Troubled Water: ECMO for the Critically Ill Newborn as a Bridging Strategy to Transplantation - Who is the Right Candidate?
Stuart Sweet, MD, PhD
New Kids on the Block: Is There a Change of Indications for Pediatric Lung and Heart-Lung Transplantation?
Bart Rottier, MD
ABO Incompatible Lung Transplantation in Infants and Small Children to Expand the Donor Pool: Where is the Age Limit and What Has To Be Considered?
Melinda Solomon, MD, FRCPC
Potts-Shunt in Children with Severe PAH: A Promising Procedure To Avoid Lung Transplantation?
Maria Gazzaneo, MD
Preview Available
Identification: SS06
Respiratory Viruses and CLAD: Epidemiology and Clinical Data
Erika Lease, MD
Respiratory Viruses and CLAD: Pathogenesis and Host Response
Tereza Martinu, MD
To Treat or Not to Treat: A Critical Review of Currently Available Therapies
Allan Glanville, MBBS, MD, FRACP
In the Pipeline: Novel Therapeutics
Christopher Ensor, PharmD
Identification: SYM010
Is the MCS Device Immunomodulatory?
Elaine Reed, PhD
Sensitization in the Pediatric MCS Population
Francesco Parisi, MD
Approach to the Sensitized MCS Patient: Desensitization and Other Strategies
Jignesh Patel, MD, PhD
Epidemiology and Risk of the Sensitized MCS Patient
Michael Shullo, PharmD
What Happens to the Antibodies After Heart Transplant?
Howard Eisen, MD
Preview Available
Identification: SYM011
Pivotal Role of the Endothelium in CAV
Daniel Jane-Wit, MD, PhD
Critical Effect of Airway Microvasculature on CLAD Development
Mark Nicolls, MD
DAMPs, PAMPS and Innate Immunity in CAV
Joren Madsen, MD DPhil
DAMPs, PAMPs, and Innate Immunity in CLAD
Scott Palmer, MD, MHS
Antibodies in CAV: the Role of Autoimmunity in Alloimmunity
Christine Lin, MD
Antibodies and B Cells in Pathogenesis of CLAD
Masaaki Sato, MD